Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.466NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.466NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.466NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
L.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
L.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
L.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.339NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.339NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.339NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.229NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.229NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.229NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.415NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.415NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.415NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.370NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.370NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.370NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.421NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.421NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.421NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.428.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.428.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.428.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.612NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.612NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.612NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.305NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.305NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.305NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.1.2.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.1.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.1.2.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.1.11.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.1.11.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
GK.1.11.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.32.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.32.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.32.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.8.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.8.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.8.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.34NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.34NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.34NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HC.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-15983.3US
B.1.1.512NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.512NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.512NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.349NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used